The Marketplace
Lonza’s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability
Lonza’s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability
Lonza | Feb 11, 2019
Lonza announces the launch of DonorPlex™ Hepatocytes, a new line of high-quality cryopreserved pooled donor suspension hepatocytes, which are the first of their kind to be produced using Lonza’s novel patented manufacturing process. Researchers within DMPK and ADME laboratories can now benefit from this reliable and robust product offering for studying the hepatic metabolism of drugs.
Explore Cells from the Inside Out
Explore Cells from the Inside Out
The Scientist Creative Services Team | Feb 11, 2019
Download this eBook from Molecular Devices to learn about the wide variety of applications used in modern cell biology!
Lonza and AllCells Join Forces for Global Commercialization of Hematopoietic Primary Cells
Lonza and AllCells Join Forces for Global Commercialization of Hematopoietic Primary Cells
Lonza | Feb 8, 2019
Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells. This partnership expands Lonza’s broad offering of hematopoietic cell lines and enables cell biologists to easily access a wide selection of high-quality cells to boost their scientific research.
Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership  to develop first in class therapies in autoimmune disease and immuno-oncology
Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership  to develop first in class therapies in autoimmune disease and immuno-oncology
Pathios Therapeutics | Feb 7, 2019
Pathios Therapeutics ("Pathios"), an innovative biotech company focused on the development of first in class therapies for autoimmune diseases and immuno-oncology and Sygnature Discovery ("Sygnature"), jointly announce a strategic partnership to accelerate Pathios’ drug discovery and development programmes.
Theraly Fibrosis Inc. Licenses Scarab Genomics’ Bacterial Production Technologies for its Pharmaceutical Program
Theraly Fibrosis Inc. Licenses Scarab Genomics’ Bacterial Production Technologies for its Pharmaceutical Program
Scarab Genomics LLC | Feb 7, 2019
Scarab Genomics LLC, a global biotechnology company focused on developing breakthrough technologies in biomanufacturing by applying its proprietary Clean Genome® E. coli expression and production systems for the manufacturing of proteins, single chain antibodies, plasmid DNA including retroviral, lentiviral, and shRNA vectors, and RNA and Theraly Fibrosis Inc., a biopharmaceutical company with a mission to develop innovative medicines for curing fibrotic diseases, today announced that they have entered into a license agreement to allow Theraly Fibrosis to fully exploit Scarab Genomics’ technology for the production of a protein for its core therapeutic program.
Tecan launches NGS DreamPrep™ delivering unprecedented speed and accuracy for automated library preparation
Tecan launches NGS DreamPrep™ delivering unprecedented speed and accuracy for automated library preparation
Tecan | Feb 7, 2019
Tecan today announces the launch of NGS DreamPrep™, a fully-automated approach to next-generation sequencing (NGS) library preparation for research use. This groundbreaking new approach offers quality controlled, sequencing-ready NGS libraries in just a matter of hours, with minimal manual interaction and no sample loss.
Ergonomic, Quiet Peltier Product for Histology
Ergonomic, Quiet Peltier Product for Histology
TECA Corporation | Feb 7, 2019
Every histology lab is different, but the need for a quiet, cold surface is universal.TECA’s newest Thermoelectric Cold Plate product offers a unique option for histology laboratories.Originally designed as a custom solution for a large histology lab, TECA has added Model ERGO-900 to our standard products line.
NanoTemper Technologies Brings Speed to Drug Discovery Screening, Launches Dianthus System
NanoTemper Technologies Brings Speed to Drug Discovery Screening, Launches Dianthus System
NanoTemper Technologies | Feb 4, 2019
 NanoTemper Technologies, maker of life science tools for protein characterization, launches its newest system, Dianthus, at the Society for Laboratory Automation and Screening (SLAS2019) conference in Washington, DC.
TS Swag: Blinding Your Sweetheart with Science!
TS Swag: Blinding Your Sweetheart with Science!
The Scientist Creative Services Team | Jan 28, 2019
Want a better present than candy and flowers for the scientist in your life? Look no further!
Pioneering Gene and Cell Therapy Solutions
Pioneering Gene and Cell Therapy Solutions
The Scientist Creative Services Team | Jan 28, 2019
Download this document from Bio-Techne to discover innovative and flexible solutions that expedite cell and gene therapy workflows.